The average BMI in our EBC patient group was 27.3 kg/m2, and the prevalence of thyroid autoantibodies was in line with the background population in Denmark, thus suggesting that the observed thyroid hormone changes in our patient group were not due to autoimmune thyroiditis related to intravenously administered trastuzumab. This evidence concerns the gene TG and autoimmune thyroid disease.